| Drug Type Gene editing | 
| Synonyms ABR 004, ABR004 | 
| Target | 
| Action inhibitors | 
| Mechanism PCSK9 inhibitors(Proprotein convertase subtilisin kexin type 9 inhibitors) | 
| Therapeutic Areas- | 
| Active Indication- | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePreclinical | 
| First Approval Date- | 
| Regulation- | 





